Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography

American Heart Journal

Volumn 145, Issue 2, 2003, Pages 285-291

  Taubert, Gunnar ^a,b   Winkelmann, Bernhard R ^a   Schleiffer, Thomas ^b   März, Winfried ^c   Winkler, Ralph ^a   Gök, Rahime ^a   Klein, Bärbel ^a   Schneider, Steffen ^a   Boehm, Bernhard O ^d  

^a Heart Center Ludwigshofen   (Germany)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

EID: 0037328965     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.134     Document Type: Article

References (32)

1. Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation 1999;100:1132-3.
2. Gillum RF, Mussolino ME, Madans JH. Diabetes mellitus, coronary heart disease incidence, and death from all causes in African American and European American women: the NHANES I epidemiologic follow-up study. J Clin Epidemiol 2000;53:511-8.
3. Currie CJ, Morgan CL, Peters JR. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes. Heart 1997;78:544-9.
4. Silva JA, Ramee SR, White CJ, et al. Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angio-graphic results and clinical outcome. Am Heart J 1999;138:446-55.
5. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
6. Melchior T, Kober L, Madsen CR, et al. Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation. Eur Heart J 1999;20:973-8.
7. Modena MG, Barbieri A. Diabetes mellitus and cardiovascular complications: pathophysiological peculiarities and therapeutic implications. Cardiologia 1999;44:865-77.
8. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus: the Finnish studies. Ann Intern Med 1996;124:127-30.
9. Malmberg K, Norhammar A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial infarction (DIGAMI) study. Circulation 1999;99:2626-32.
10. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multipte Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
11. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100:1134-46.
12. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998;21:1138-45.
13. Thefeld W. Prevalence of diabetes mellitus in the adult German population. Gesundheitswesen 1999;61:S85-9.
14. Palitzsch KD, Nusser J, Arndt H, et al. The prevalence of diabetes mellitus is significantly underestimated in Germany, according to a nationwide epidemiological study based on HbA1c analysis. Diabet Stoffw 1999;8:189-200.
15. Levetan CS, Passaro M, Jablonski K, et al. Unrecognized diabetes among hospitalized patients. Diabetes Care 1998;21:246-9.
16. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
17. Scott R, Lintott CJ, Zimmet P, et al. Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus? Diabetes Res Clin Pract 1999;43:179-85.
18. Haffner SM, Alexander CM, Cook TJ, et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med 1999;159:2661-7.
19. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65.
20. Winkelmann BR, Maerz W, Boehm BO, et al. Rationale and design of the Ludwigshofen Risk and Cardiovascular Health Study (LURIC). Pharmacogenomics 2001;2(1 Suppl):1-71.
21. WHO Study Group. Diabetes mellitus. Geneva: World Health Organ Tech Rep Ser; 1985. p. 1-113, 727.
22. American Diabetes Association. Clinical practice recommendations 2000. Diabetes Care 2000;23:S20-3.
23. European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999;16:716-30.
24. Friesinger GC, Page EE, Ross RS. Prognostic significance of coronary arteriography. Trans Assoc Am Physicians 1970:83;78-92.
25. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-24.
26. Tenenbaum A, Fisman EZ, Boyko V, et al. Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Am J Cardiol 1999;84:294-8.
27. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) VIII: study design, progress and performance. Diabetologia 1991;34:877-90.
28. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-8.
29. Natali A, Vichi S, Landi P, et al. Coronary atherosclerosis in type II diabetes: angiographic findings and clinical outcome. Diabetologia 2000;43:632-41.
30. Brun E, Nelson RG, Bennett PH, et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000;23:1119-23.
31. DECODE study group. Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 1999;22:1667-71.
32. Clark CM, Fradkin JE, Hiss RG, et al. Promoting early diagnosis and treatment of type 2 diabetes: the National Diabetes Education Program. JAMA 2000;284:363-5.